Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

A case in point is Mission Bio, a U.S-based biotechnology company that in June 2024, launched Tapestri Single-cell Multiple Myeloma Multiomics Solution, enabling comprehensive profiling of ...

A case in point is Mission Bio, a U.S-based biotechnology company that in June 2024, launched Tapestri Single-cell Multiple Myeloma Multiomics Solution, enabling comprehensive profiling of multiple ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Dr. Usmani has more than 15 years of experience specializing in the care of patients with multiple myeloma and other disorders affecting plasma cells. Here Dr. Usmani discusses the current outlook for ...

The Oregon Stem Cell Center conducts basic and applied research in the field of Stem Cell Biology with the long term goal to harness the properties of stem cells for regenerative medicine and cell ...

Multiple myeloma cells are blood cells that have undergone genetic mutations. These mutations can occur different ways, and one of the most important distinctions is hyperdiploid cells vs. hypodiploid ...

1School of Basic Medical Science, Southern Medical University, Guangzhou, China. 2Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. 3Zenith Institute of ...

In general, chemotherapy medications work by attacking cells or by preventing them from growing and dividing. Cancer cells tend to grow and divide rapidly and uncontrollably, and many chemotherapy ...